Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Med LifeLTS:0RO5 +2.15%62 Cash Ratio is 0.18 as of Mar. 2026, which is at its 10-year median of 0.18. GuruFocus rates LTS:0RO5 with a GF Score™ of 62/100 and a GF Value™ of lei1.51 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Med Life ranks worse than 80.15% on this metric.
Med Life has a Cash Ratio of 0.18. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Med Life's Cash Ratio or its related term are showing as below:
LTS:0RO5'
s Cash Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.18 Max: 0.48
Current: 0.18
During the past 11 years, Med Life's highest Cash Ratio was 0.48. The lowest was 0.07. And the median was 0.18.
LTS:0RO5's Cash Ratio is ranked worse than 80.15% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 0.58
vs LTS:0RO5: 0.18
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Med Life Cash Ratio Related Terms
Med Life Cash Ratio Historical Data
* Premium members only.
The historical data trend for Med Life's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Med Life's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Med Life's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med Life (LTS:0RO5) has a Cash Ratio of 0.18 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Med Life and its competitors. This is near median its historical median of 0.18. Over the past decade, Med Life's Cash Ratio has ranged from 0.07 to 0.48. According to the industry distribution chart, Med Life ranks #533 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 80.2%.
Is Med Life's Cash Ratio too high?
Med Life's current Cash Ratio of 0.18 is near median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.48. The Healthcare Providers & Services industry median Cash Ratio is 0.58. Med Life's value of 0.18 is 69% below this industry median. Based on the distribution chart, Med Life ranks #533 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Med Life has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Cash Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #533 out of 665 companies for Cash Ratio. This places Med Life in the lower half of its industry. The industry median Cash Ratio is 0.58. Med Life's value of 0.18 is 69% below this benchmark. Historically, Med Life's own Cash Ratio has ranged from 0.07 to 0.48 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.58, Med Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current Cash Ratio of 0.18 is 69% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current Cash Ratio is 0.18, which is near median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.51, compared to a current price of lei11.62 — trading 669.5% above its estimated fair value. The current Cash Ratio is 0.18, which is near median its 10-year median of 0.18 and 69% below the Healthcare Providers & Services industry median of 0.58. Med Life's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current Cash Ratio is 0.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (LTS:0RO5) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.62 is trading 669.5% above its estimated GF Value™ of lei1.51.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for LTS:0RO5:
Cash Ratio: 0.18 (near median its 10-year median of 0.18)
GF Value™: lei1.51 vs. price of lei11.62 (669.5% above fair value)
Industry Position: 69% below the Healthcare Providers & Services median (#533 of 665)
No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
62GF Score
Get the complete analysis for LTS:0RO5
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RO5 has been successfully added to your 
